Total Liabilities Summary of BIOTON S.A.

BIOTON S.A.'s latest annual total liabilities in 2023 was 215.86 Million PLN , up 5.68% from previous year.
BIOTON S.A.'s latest quarterly total liabilities in 2024 Q2 was 185.73 Million PLN , up 2.49% from previous quarter.
BIOTON S.A. reported annual total liabilities of 204.26 Million PLN in 2022, down -15.75% from previous year.
BIOTON S.A. reported annual total liabilities of 242.45 Million PLN in 2021, down -2.03% from previous year.
BIOTON S.A. reported quarterly total liabilities of 195.63 Million PLN for 2024 Q1, down -9.37% from previous quarter.
BIOTON S.A. reported quarterly total liabilities of 215.86 Million PLN for 2023 FY, up 5.68% from previous quarter.

Annual Total Liabilities Chart of BIOTON S.A. (2023 - 2005)

Historical Annual Total Liabilities of BIOTON S.A. (2023 - 2005)

Year	Total Liabilities	Total Liabilities Growth
2023	215.86 Million PLN	5.68%
2022	204.26 Million PLN	-15.75%
2021	242.45 Million PLN	-2.03%
2020	247.46 Million PLN	-17.35%
2019	299.41 Million PLN	0.74%
2018	297.23 Million PLN	-19.39%
2017	368.71 Million PLN	-23.4%
2016	481.36 Million PLN	8.56%
2015	443.41 Million PLN	-12.77%
2014	508.31 Million PLN	0.52%
2013	505.68 Million PLN	-12.62%
2012	578.69 Million PLN	-9.53%
2011	639.67 Million PLN	55.34%
2010	411.78 Million PLN	-21.54%
2009	524.84 Million PLN	-36.54%
2008	827.08 Million PLN	25.44%
2007	659.35 Million PLN	259.27%
2006	183.52 Million PLN	78.69%
2005	102.7 Million PLN	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	185.73 Million PLN	2.49%
2024 Q1	195.63 Million PLN	-9.37%
2023 FY	215.86 Million PLN	5.68%
2023 Q1	209.97 Million PLN	2.79%
2023 Q3	220.24 Million PLN	4.2%
2023 Q2	211.35 Million PLN	0.66%
2023 Q4	215.86 Million PLN	-1.99%
2022 Q2	218.05 Million PLN	-2.22%
2022 Q1	223 Million PLN	-8.02%
2022 FY	204.26 Million PLN	-15.75%
2022 Q4	204.26 Million PLN	-12.76%
2022 Q3	234.14 Million PLN	7.38%
2021 FY	242.45 Million PLN	-2.03%
2021 Q2	236.67 Million PLN	-3.02%
2021 Q1	244.05 Million PLN	-1.38%
2021 Q3	243.21 Million PLN	2.76%
2021 Q4	242.45 Million PLN	-0.31%
2020 FY	247.46 Million PLN	-17.35%
2020 Q2	286.47 Million PLN	-5.38%
2020 Q3	279.2 Million PLN	-2.54%
2020 Q4	247.46 Million PLN	-11.37%
2020 Q1	302.76 Million PLN	1.12%
2019 FY	299.41 Million PLN	0.74%
2019 Q1	297.72 Million PLN	0.17%
2019 Q2	280.58 Million PLN	-5.76%
2019 Q3	293.07 Million PLN	4.45%
2019 Q4	299.41 Million PLN	2.16%
2018 FY	297.23 Million PLN	-19.39%
2018 Q4	297.23 Million PLN	12.14%
2018 Q1	345.23 Million PLN	-6.37%
2018 Q2	336.04 Million PLN	-2.66%
2018 Q3	265.05 Million PLN	-21.13%
2017 Q4	368.71 Million PLN	-3.4%
2017 Q2	391.58 Million PLN	-11.01%
2017 Q1	440.02 Million PLN	-8.59%
2017 FY	368.71 Million PLN	-23.4%
2017 Q3	381.69 Million PLN	-2.53%
2016 Q3	431.14 Million PLN	0.22%
2016 Q1	424.78 Million PLN	-4.2%
2016 FY	481.36 Million PLN	8.56%
2016 Q2	430.2 Million PLN	1.28%
2016 Q4	481.36 Million PLN	11.65%
2015 Q1	515.62 Million PLN	1.44%
2015 FY	443.41 Million PLN	-12.77%
2015 Q4	443.41 Million PLN	-16.38%
2015 Q3	530.29 Million PLN	-1.15%
2015 Q2	536.47 Million PLN	4.04%
2014 Q3	550.79 Million PLN	7.11%
2014 Q4	508.31 Million PLN	-7.71%
2014 Q2	514.25 Million PLN	-3.15%
2014 FY	508.31 Million PLN	0.52%
2014 Q1	530.97 Million PLN	5.0%
2013 Q3	519.17 Million PLN	-11.96%
2013 Q4	505.68 Million PLN	-2.6%
2013 FY	505.68 Million PLN	-12.62%
2013 Q1	603.04 Million PLN	4.21%
2013 Q2	589.7 Million PLN	-2.21%
2012 Q3	617.83 Million PLN	-1.43%
2012 Q1	593.88 Million PLN	-7.16%
2012 Q4	578.69 Million PLN	-6.34%
2012 FY	578.69 Million PLN	-9.53%
2012 Q2	626.76 Million PLN	5.54%
2011 Q3	484.64 Million PLN	6.54%
2011 Q4	639.67 Million PLN	31.99%
2011 FY	639.67 Million PLN	55.34%
2011 Q1	413.69 Million PLN	0.47%
2011 Q2	454.9 Million PLN	9.96%
2010 Q2	403.32 Million PLN	-28.1%
2010 Q1	560.98 Million PLN	6.89%
2010 FY	411.78 Million PLN	-21.54%
2010 Q4	411.78 Million PLN	-0.87%
2010 Q3	415.41 Million PLN	3.0%
2009 Q4	524.84 Million PLN	0.0%
2009 FY	524.84 Million PLN	-36.54%
2008 FY	827.08 Million PLN	25.44%
2007 FY	659.35 Million PLN	259.27%
2006 FY	183.52 Million PLN	78.69%
2005 FY	102.7 Million PLN	0.0%

Peer Total Liabilities Comparison of BIOTON S.A.

Name	Total Liabilities	Total Liabilities Difference
Bioceltix S.A.	2.26 Million PLN	-9415.48%
Captor Therapeutics Spolka Akcyjna	28.07 Million PLN	-668.918%
Mabion S.A.	90.47 Million PLN	-138.584%
Molecure S.A.	11.34 Million PLN	-1802.792%
NanoGroup S.A.	1.49 Million PLN	-14386.708%
Pharmena S.A.	1.9 Million PLN	-11225.603%
Poltreg S.A.	39.58 Million PLN	-445.378%
Pure Biologics Spólka Akcyjna	20.84 Million PLN	-935.577%
Ryvu Therapeutics S.A.	120.36 Million PLN	-79.35%
Synthaverse S.A.	153.26 Million PLN	-40.846%
Urteste S.A.	1.85 Million PLN	-11536.981%

Global Stocks Search

BIOTON S.A. (BIO.WA)

Total Liabilities Summary of BIOTON S.A.

Annual Total Liabilities Chart of BIOTON S.A. (2023 - 2005)

Historical Annual Total Liabilities of BIOTON S.A. (2023 - 2005)

Peer Total Liabilities Comparison of BIOTON S.A.